410 related articles for article (PubMed ID: 20412570)
1. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report.
Zuccoli G; Marcello N; Pisanello A; Servadei F; Vaccaro S; Mukherjee P; Seyfried TN
Nutr Metab (Lond); 2010 Apr; 7():33. PubMed ID: 20412570
[TBL] [Abstract][Full Text] [Related]
2. Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.
Elsakka AMA; Bary MA; Abdelzaher E; Elnaggar M; Kalamian M; Mukherjee P; Seyfried TN
Front Nutr; 2018; 5():20. PubMed ID: 29651419
[TBL] [Abstract][Full Text] [Related]
3. Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of
Seyfried TN; Shivane AG; Kalamian M; Maroon JC; Mukherjee P; Zuccoli G
Front Nutr; 2021; 8():682243. PubMed ID: 34136522
[No Abstract] [Full Text] [Related]
4. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.
Zhou W; Mukherjee P; Kiebish MA; Markis WT; Mantis JG; Seyfried TN
Nutr Metab (Lond); 2007 Feb; 4():5. PubMed ID: 17313687
[TBL] [Abstract][Full Text] [Related]
5. Treatment of glioblastoma multiforme with "classic" 4:1 ketogenic diet total meal replacement.
Klein P; Tyrlikova I; Zuccoli G; Tyrlik A; Maroon JC
Cancer Metab; 2020 Nov; 8(1):24. PubMed ID: 33292598
[TBL] [Abstract][Full Text] [Related]
6. Case report: Resolution of malignant canine mast cell tumor using ketogenic metabolic therapy alone.
Seyfried TN; Mukherjee P; Lee DC; Ta L; Nations L
Front Nutr; 2023; 10():1157517. PubMed ID: 37057065
[TBL] [Abstract][Full Text] [Related]
7. Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme.
Maroon J; Bost J; Amos A; Zuccoli G
J Child Neurol; 2013 Aug; 28(8):1002-8. PubMed ID: 23670248
[TBL] [Abstract][Full Text] [Related]
8. Ketogenic metabolic therapy in conjunction with standard treatment for glioblastoma: A case report.
Phillips MCL; Thotathil Z; Dass PH; Ziad F; Moon BG
Oncol Lett; 2024 May; 27(5):230. PubMed ID: 38586213
[TBL] [Abstract][Full Text] [Related]
9. Metabolic therapy: a new paradigm for managing malignant brain cancer.
Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
[TBL] [Abstract][Full Text] [Related]
10. The role of metabolic therapy in treating glioblastoma multiforme.
Maroon JC; Seyfried TN; Donohue JP; Bost J
Surg Neurol Int; 2015; 6():61. PubMed ID: 25949849
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Effects of a Ketogenic Diet on [
Cussó L; Musteanu M; Mulero F; Barbacid M; Desco M
Mol Imaging Biol; 2019 Apr; 21(2):279-285. PubMed ID: 29968182
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Feasibility and Effects of a Ketogenic Diet in Patients With CNS Malignancies: A Retrospective Case Series.
Panhans CM; Gresham G; Amaral LJ; Hu J
Front Neurosci; 2020; 14():390. PubMed ID: 32508561
[No Abstract] [Full Text] [Related]
14. Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series.
Phillips MCL; Leyden J; McManus EJ; Lowyim DG; Ziad F; Moon BG; Haji Mohd Yasin NAB; Tan A; Thotathil Z; Jameson MB
J Oncol; 2022; 2022():4496734. PubMed ID: 36276276
[TBL] [Abstract][Full Text] [Related]
15. Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study.
Martin-McGill KJ; Marson AG; Tudur Smith C; Jenkinson MD
Pilot Feasibility Stud; 2017; 3():67. PubMed ID: 29209515
[TBL] [Abstract][Full Text] [Related]
16. Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma.
Augur ZM; Doyle CM; Li M; Mukherjee P; Seyfried TN
Front Nutr; 2018; 5():91. PubMed ID: 30349820
[No Abstract] [Full Text] [Related]
17. Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
Seyfried TN; Shelton L; Arismendi-Morillo G; Kalamian M; Elsakka A; Maroon J; Mukherjee P
Neurochem Res; 2019 Oct; 44(10):2392-2404. PubMed ID: 31025151
[TBL] [Abstract][Full Text] [Related]
18. Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets.
Mantis JG; Fritz CL; Marsh J; Heinrichs SC; Seyfried TN
Epilepsy Behav; 2009 Jun; 15(2):133-41. PubMed ID: 19249385
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.
Mukherjee P; Augur ZM; Li M; Hill C; Greenwood B; Domin MA; Kondakci G; Narain NR; Kiebish MA; Bronson RT; Arismendi-Morillo G; Chinopoulos C; Seyfried TN
Commun Biol; 2019; 2():200. PubMed ID: 31149644
[TBL] [Abstract][Full Text] [Related]
20. The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the Literature.
Varshneya K; Carico C; Ortega A; Patil CG
Cureus; 2015 Feb; 7(2):e251. PubMed ID: 26180675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
